Streptococcus equi subsp. zooepidemicus Farrow and Collins 拉丁名
(ATCC 39920) 统一编号
Strain Designations 菌株别名 HA-116
Application 用途 Produces hyaluronic acid
Production of high molecular weight hyaluronic acid
Isolation 分离基物 Nitrosoguanidine-induced mutant of clinical isolate HA-100
Type Strain 模式菌株 no
Biosafety Level 生物安全等级 2
Product Format 提供形式 freeze-dried
Storage Conditions 保藏条件
Frozen 冷冻物: -80℃ or colder
Freeze-Dried 冻干物: 2℃ to 8℃
Live Culture 活物: See Propagation Section
Preceptrol no
Type Strain 模式菌株 no
Medium 培养基 ATCC Medium 44: Brain Heart Infusion Agar/Broth
ATCC Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
Growth Conditions 生长条件
Temperature 培养温度: 37℃
Atmosphere 需氧情况: Aerobic
Name of Depositor 寄存人 Biotechnology General Corp.
U.S. Patent Number
4,780,414
Disclosure
This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
Isolation
Nitrosoguanidine-induced mutant of clinical isolate HA-100
References 参考文献 Nimrod A, et al. Method of producing high molecular weight sodium hyallronate by fermentation of Streptococcus. US Patent 4,780,414 dated Oct 25 1988
Nimrod A, et al. High molecular weight sodium hyaluronate. US Patent 4,784,990 dated Nov 15 1988